Hereditary Angioedema Treatment Market Analysis, Research Report, Growth Analysis Foresight up to 2025

1
Pune, India, 3rd May, 2019 The global hereditary
angioedema treatment market to gain from
increasing incidences of genetic mutation.
Recently Fortune Business Insights, published a
report titled, Hereditary Angioedema Treatment
Market Size, Share and Global Trend by Drug Class
(C-1 Esterase Inhibitors, Bradykynin Receptor
Antagonist, Kallikrein Inhibitors), Application
(Prophylaxis, Treatment), Route of Administration
(IV, Subcutaneous), Distribution Channel
(Hospital Pharmacy, Retail Pharmacy) and
Geography Forecast till 2025. As per the report,
the global hereditary angioedema treatment
market was worth US 1883.1 Mn in 2017. The
global market is anticipated to expand at a CAGR
of 16.8 and reach US 6533.3 Mn by the end of
2025. The report classifies the global
hereditary angioedema treatment market in various
segments and offer a comprehensive
overview. According to the report, the
hereditary angioedema treatment market in North
America was valued at US 1752.2 Mn in 2017. The
growth witnessed is attributable to high
prevalence of hereditary angioedema in the
region. North America may remain dominant in the
global market through the forecast period
(2018-2025) also. Presence of an established
healthcare system and increasing healthcare
expenditure are a few factors anticipated to
contribute the expansion of the hereditary
angioedema treatment market in North America. The
report also predicts the market in Asia Pacific
to witness impressive growth. Increasing medical
tourism in nations such as China and India will
create lucrative growth opportunities for the
market in the region. Besides this, increasing
number of product innovations in the region
backed by high presence of hereditary angioedema
drugs manufacturers will give tailwinds to growth
witnessed by the hereditary angioedema treatment
market. Get Sample PDF https//www.fortunebusine
ssinsights.com/enquiry/request-sample-pdf/heredita
ry- angioedema-treatment-market-100164 C-1
Esterase Inhibitor Segment to Dominate Global
Market During Forecast Period In terms of drug
class, the C-1 esterase inhibitor is the most
popular drug and dominated the global hereditary
angioedema treatment market in 2017. The segment
accounted for 61.3 of the global market in
2017. The trend is unlikely to change during the
forecast period 2018-2025 owing to the drugs
reliability among patients and practitioners. Inc
reasing awareness about the disorder and rising
prevalence of the hereditary angioedema are some
factors expected to drive the global hereditary
angioedema treatment market during the forecast
period. Additionally, technological developments
in the hereditary angioedema treatment devices
and equipment is expected to boost the global
market.
2
According to the U.S. Hereditary Angioedema
Association, hereditary angioedema may not
necessarily occur due to prior familial history
of the disease. In 25 of the cases hereditary
angioedema may arise due to spontaneous mutation
of the gene called C-1 inhibitor. This is
anticipated to enable growth in the global
hereditary angioedema treatment market. On the
flip side, the side effects and high cost
associated with hereditary angioedema drugs and
treatment is the major factor that may restrain
the global hereditary angioedema treatment
market. Shire, CSL Behring, and Pharming Group
NV to Lead the Global Market The global
hereditary angioedema treatment market is
witnessing entry of new players in the market.
However, at present Pharming Group NV, Shire, and
CSL Behring are together leading the global
market owing to the organizations strong
distribution network. Some of the other
companies operating in the global hereditary
angioedema treatment market are BIOCRYST
PHARMACEUTICALS INC., Ionis Pharmaceuticals Inc.,
Attune Pharmaceuticals, Arrowhead
Pharmaceuticals Inc., and Adverum. Browse
Complete Report https//www.fortunebusinessinsigh
ts.com/industry-reports/hereditary-angioedema-trea
tment-market- 100164 About us Fortune
Business Insights offers expert corporate
analysis and accurate data, helping
organizations of all sizes make timely decisions.
We tailor innovative solutions for our clients,
assisting them address challenges distinct to
their businesses. Our goal is to empower our
clients with holistic market intelligence,
giving a granular overview of the market they are
operating in. Our reports contain a unique mix
of tangible insights and qualitative analysis to
help companies achieve sustainable growth. Our
team of experienced analysts and consultants use
industry- leading research tools and techniques
to compile comprehensive market studies,
interspersed with relevant data. At Fortune
Business Insights we aim at highlighting the most
lucrative growth opportunities for our clients.
We therefore offer recommendations, making it
easier for them to navigate through
technological and market-related changes. Our
consulting services are designed to help
organizations identify hidden opportunities and
understand prevailing competitive challenges.